Taiyen Biotech Past Earnings Performance
Past criteria checks 2/6
Taiyen Biotech has been growing earnings at an average annual rate of 0.1%, while the Food industry saw earnings growing at 4.1% annually. Revenues have been growing at an average rate of 3% per year. Taiyen Biotech's return on equity is 3.4%, and it has net margins of 9.2%.
Key information
0.1%
Earnings growth rate
0.1%
EPS growth rate
Food Industry Growth | 7.3% |
Revenue growth rate | 3.0% |
Return on equity | 3.4% |
Net Margin | 9.2% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20
Jul 31Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality
May 09Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher
Apr 09A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Mar 25Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?
Mar 12Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?
Feb 14Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend
Feb 01Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)
Jan 04A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Dec 22How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?
Dec 09Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return
Nov 24Revenue & Expenses Breakdown
How Taiyen Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 3,220 | 298 | 946 | 55 |
30 Jun 24 | 3,302 | 358 | 947 | 57 |
31 Mar 24 | 3,357 | 297 | 918 | 58 |
31 Dec 23 | 3,409 | 300 | 876 | 60 |
30 Sep 23 | 3,486 | 389 | 816 | 61 |
30 Jun 23 | 3,541 | 399 | 792 | 62 |
31 Mar 23 | 3,555 | 408 | 775 | 61 |
31 Dec 22 | 3,614 | 427 | 771 | 61 |
30 Sep 22 | 3,969 | 419 | 785 | 59 |
30 Jun 22 | 4,116 | 357 | 785 | 59 |
31 Mar 22 | 4,229 | 418 | 790 | 58 |
31 Dec 21 | 4,096 | 393 | 786 | 58 |
30 Sep 21 | 3,758 | 431 | 760 | 56 |
30 Jun 21 | 3,391 | 427 | 754 | 56 |
31 Mar 21 | 3,196 | 402 | 769 | 68 |
31 Dec 20 | 3,130 | 365 | 770 | 74 |
30 Sep 20 | 3,008 | 318 | 767 | 82 |
30 Jun 20 | 3,027 | 308 | 762 | 87 |
31 Mar 20 | 2,955 | 316 | 735 | 76 |
31 Dec 19 | 2,907 | 346 | 722 | 69 |
30 Sep 19 | 2,905 | 335 | 736 | 62 |
30 Jun 19 | 2,878 | 337 | 716 | 57 |
31 Mar 19 | 2,996 | 460 | 733 | 57 |
31 Dec 18 | 3,001 | 453 | 724 | 58 |
30 Sep 18 | 2,933 | 452 | 697 | 58 |
30 Jun 18 | 2,925 | 475 | 692 | 59 |
31 Mar 18 | 2,783 | 375 | 667 | 58 |
31 Dec 17 | 2,757 | 354 | 663 | 57 |
30 Sep 17 | 2,749 | 357 | 669 | 56 |
30 Jun 17 | 2,747 | 347 | 673 | 55 |
31 Mar 17 | 2,782 | 349 | 691 | 55 |
31 Dec 16 | 2,755 | 352 | 685 | 54 |
30 Sep 16 | 2,762 | 317 | 681 | 56 |
30 Jun 16 | 2,752 | 338 | 682 | 55 |
31 Mar 16 | 2,751 | 289 | 668 | 54 |
31 Dec 15 | 2,761 | 269 | 679 | 54 |
30 Sep 15 | 2,722 | 289 | 674 | 55 |
30 Jun 15 | 2,669 | 223 | 676 | 56 |
31 Mar 15 | 2,608 | 186 | 691 | 56 |
31 Dec 14 | 2,576 | 214 | 686 | 57 |
30 Sep 14 | 2,566 | 210 | 679 | 58 |
30 Jun 14 | 2,507 | 181 | 673 | 58 |
31 Mar 14 | 2,475 | 161 | 671 | 61 |
31 Dec 13 | 2,409 | 126 | 659 | 65 |
Quality Earnings: 1737 has high quality earnings.
Growing Profit Margin: 1737's current net profit margins (9.2%) are lower than last year (11.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1737's earnings have grown by 0.1% per year over the past 5 years.
Accelerating Growth: 1737's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1737 had negative earnings growth (-23.4%) over the past year, making it difficult to compare to the Food industry average (17.4%).
Return on Equity
High ROE: 1737's Return on Equity (3.4%) is considered low.